{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:15:58Z","timestamp":1793502958052,"version":"4.5.0"},"reference-count":110,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1097\/med.0b013e328350a6e1","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T16:06:45Z","timestamp":1377878805000},"page":"128-135","source":"Crossref","is-referenced-by-count":124,"title":["Type 2 diabetes and bone fractures"],"prefix":"10.1097","volume":"19","author":[{"given":"Kendall F.","family":"Moseley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20211004","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00198-008-0559-5","article-title":"3rd, et al. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.","volume":"19","author":"Dawson-Hughes","year":"2008","journal-title":"Osteoporos Int"},{"key":"R2-11-20211004","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00198-010-1288-0","article-title":"Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance.","volume":"22","author":"Looker","year":"2010","journal-title":"Osteoporos Int"},{"key":"R3-11-20211004","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1046\/j.1532-5415.2002.50455.x","article-title":"Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study.","volume":"50","author":"Leibson","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"R4-11-20211004","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s001980170015","article-title":"Impact of hip and vertebral fractures on quality-adjusted life years.","volume":"12","author":"Tosteson","year":"2001","journal-title":"Osteoporos Int"},{"key":"R5-11-20211004","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.archger.2004.10.003","article-title":"Functional recovery after hip fracture in old-old elderly patients.","volume":"40","author":"Arinzon","year":"2005","journal-title":"Arch Gerontol Geriatr"},{"key":"R6-11-20211004","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1055\/s-0030-1270466","article-title":"Mortality after hip fracture in diabetic patients.","volume":"119","author":"Gulcelik","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R7-11-20211004","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00198-003-1385-4","article-title":"3rd, Gabriel SE, Crowson CS, et al. Cost-equivalence of different osteoporotic fractures.","volume":"14","author":"Melton","year":"2003","journal-title":"Osteoporos Int"},{"key":"R8-11-20211004","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","article-title":"3rd, Dawson-Hughes B, et al. Cost-effective osteoporosis treatment thresholds: the United States perspective.","volume":"19","author":"Tosteson","year":"2008","journal-title":"Osteoporos Int"},{"key":"R9-11-20211004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00198-009-1034-7","article-title":"The potential impact of new National Osteoporosis Foundation guidance on treatment patterns.","volume":"21","author":"Dawson-Hughes","year":"2010","journal-title":"Osteoporos Int"},{"key":"R10-11-20211004","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-122-6-199503150-00002","article-title":"Bone density in noninsulin-dependent diabetes mellitus. The Rotterdam Study.","volume":"122","author":"van Daele","year":"1995","journal-title":"Ann Intern Med"},{"key":"R11-11-20211004","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00125-006-0154-2","article-title":"Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study.","volume":"49","author":"Rakic","year":"2006","journal-title":"Diabetologia"},{"key":"R12-11-20211004","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1007\/s00198-005-1863-y","article-title":"Body mass index as a predictor of fracture risk: a meta-analysis.","volume":"16","author":"De Laet","year":"2005","journal-title":"Osteoporos Int"},{"key":"R13-11-20211004","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/jbmr.5650080604","article-title":"Determinants of bone mineral density and risk factors for osteoporosis in healthy elderly women.","volume":"8","author":"Ooms","year":"1993","journal-title":"J Bone Miner Res"},{"key":"R14-11-20211004","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1359\/jbmr.2003.18.10.1766","article-title":"Structural and biomechanical basis of sexual dimorphism in femoral neck fragility has its origins in growth and aging.","volume":"18","author":"Duan","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R15-11-20211004","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1359\/jbmr.2001.16.6.1108","article-title":"Structural adaptation to changing skeletal load in the progression toward hip fragility: the study of osteoporotic fractures.","volume":"16","author":"Beck","year":"2001","journal-title":"J Bone Miner Res"},{"key":"R16-11-20211004","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1359\/jbmr.071016","article-title":"Lean mass and not fat mass is associated with male proximal femur strength.","volume":"23","author":"Travison","year":"2008","journal-title":"J Bone Miner Res"},{"key":"R17-11-20211004","first-page":"1388","article-title":"Does hyperinsulinemia preserve bone Diabetes C","volume":"19","author":"Barrett-Connor","year":"1996","journal-title":"are"},{"key":"R18-11-20211004","doi-asserted-by":"crossref","first-page":"E735","DOI":"10.1152\/ajpendo.00159.2005","article-title":"Is insulin an anabolic agent in bone Dissecting the diabetic bone for clues.","volume":"289","author":"Thrailkill","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R19-11-20211004","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bone.2010.12.016","article-title":"Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone.","volume":"48","author":"Nyman","year":"2011","journal-title":"Bone"},{"key":"R20-11-20211004","first-page":"12","article-title":"Bone mineral density and fracture risk in patients with type 1 and type 2 diabetes mellitus.","volume":"51","author":"Botushanov","year":"2009","journal-title":"Folia Med (Plovdiv)"},{"key":"R21-11-20211004","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF03351073","article-title":"Osteoporosis and risk of fracture in patients with diabetes: an update.","volume":"23","author":"Montagnani","year":"2011","journal-title":"Aging Clin Exp Res"},{"key":"R22-11-20211004","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/157339910791162970","article-title":"Bone disease in diabetes.","volume":"6","author":"Isidro","year":"2010","journal-title":"Curr Diabetes Rev"},{"key":"R23-11-20211004","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11914-007-0025-x","article-title":"Diabetes, fracture, and bone fragility.","volume":"5","author":"Schwartz","year":"2007","journal-title":"Curr Osteoporos Rep"},{"key":"R24-11-20211004","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00198-005-1909-1","article-title":"Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study.","volume":"16","author":"de Liefde","year":"2005","journal-title":"Osteoporos Int"},{"key":"R25-11-20211004","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jcem.86.1.7139","article-title":"Older women with diabetes have an increased risk of fracture: a prospective study.","volume":"86","author":"Schwartz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-11-20211004","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/archinte.165.14.1612","article-title":"Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study.","volume":"165","author":"Strotmeyer","year":"2005","journal-title":"Arch Intern Med"},{"key":"R27-11-20211004","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/dc06-0440","article-title":"Prospective study of diabetes and risk of hip fracture: the Nurses Health Study.","volume":"29","author":"Janghorbani","year":"2006","journal-title":"Diabetes Care"},{"key":"R28-11-20211004","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1210\/jc.2005-2226","article-title":"Thiazolidinedione use and bone loss in older diabetic adults.","volume":"91","author":"Schwartz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-11-20211004","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2337\/dc07-1736","article-title":"Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study.","volume":"31","author":"Monami","year":"2008","journal-title":"Diabetes Care"},{"key":"R30-11-20211004","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00223-010-9352-5","article-title":"The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone increases bone resorption in women with type 2 diabetes: a randomized, controlled trial.","volume":"86","author":"Gruntmanis","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"R31-11-20211004","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jc.2006-2646","article-title":"The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial.","volume":"92","author":"Grey","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-11-20211004","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc07-2270","article-title":"Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).","volume":"31","author":"Kahn","year":"2008","journal-title":"Diabetes Care"},{"key":"R33-11-20211004","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1001\/archinte.168.8.820","article-title":"Use of thiazolidinediones and fracture risk.","volume":"168","author":"Meier","year":"2008","journal-title":"Arch Intern Med"},{"key":"R34-11-20211004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MED.0b013e328325d155","article-title":"Bone metabolism in type 2 diabetes and role of thiazolidinediones.","volume":"16","author":"Vestergaard","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R35-11-20211004","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1001\/jama.299.23.2751","article-title":"Examining a bidirectional association between depressive symptoms and diabetes.","volume":"299","author":"Golden","year":"2008","journal-title":"JAMA"},{"key":"R36-11-20211004","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2337\/dc08-0985","article-title":"Depression and type 2 diabetes over the lifespan: a meta-analysis.","volume":"31","author":"Mezuk","year":"2008","journal-title":"Diabetes Care"},{"key":"R37-11-20211004","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1053\/j.gastro.2011.06.011","article-title":"The Importance of the Gastrointestinal Tract in the Control of Bone Mass Accrual.","volume":"141","author":"Karsenty","year":"2011","journal-title":"Gastroenterology"},{"key":"R38-11-20211004","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cell.2009.06.051","article-title":"A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure.","volume":"138","author":"Yadav","year":"2009","journal-title":"Cell"},{"key":"R39-11-20211004","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1210\/jc.2010-1030","article-title":"The central regulation of bone mass, the first link between bone remodeling and energy metabolism.","volume":"95","author":"Karsenty","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R40-11-20211004","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/archinte.167.12.1240","article-title":"Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures.","volume":"167","author":"Diem","year":"2007","journal-title":"Arch Intern Med"},{"key":"R41-11-20211004","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/archinte.167.12.1246","article-title":"Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.","volume":"167","author":"Haney","year":"2007","journal-title":"Arch Intern Med"},{"key":"R42-11-20211004","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/YIC.0b013e3282f2b3bb","article-title":"Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression.","volume":"23","author":"Williams","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"R43-11-20211004","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archinte.167.2.188","article-title":"Effect of selective serotonin reuptake inhibitors on the risk of fracture.","volume":"167","author":"Richards","year":"2007","journal-title":"Arch Intern Med"},{"key":"R44-11-20211004","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1359\/jbmr.061017","article-title":"Predictors of nonspine fracture in elderly men: the MrOS study.","volume":"22","author":"Lewis","year":"2007","journal-title":"J Bone Miner Res"},{"key":"R45-11-20211004","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jbmr.462","article-title":"LRP5, serotonin and bone: complexity, contradictions and conundrums.","volume":"26","author":"Goltzman","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R46-11-20211004","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jdiacomp.2011.02.004","article-title":"Prevalence of osteoporosis and vertebral fractures in postmenopausal women with type 2 diabetes mellitus and their relationship with duration of the disease and chronic complications.","volume":"25","author":"Viegas","year":"2011","journal-title":"J Diabetes Complications"},{"key":"R47-11-20211004","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2337\/dc07-1152","article-title":"Diabetes-related complications, glycemic control, and falls in older adults.","volume":"31","author":"Schwartz","year":"2008","journal-title":"Diabetes Care"},{"key":"R48-11-20211004","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1530\/acta.0.0960081","article-title":"Hypoparathyroidism in diabetes mellitus.","volume":"96","author":"McNair","year":"1981","journal-title":"Acta Endocrinol (Copenh)"},{"key":"R49-11-20211004","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/ATVBAHA.109.200154","article-title":"Diabetes mellitus induces bone marrow microangiopathy.","volume":"30","author":"Oikawa","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R50-11-20211004","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.prs.0000244830.16906.3f","article-title":"Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia.","volume":"119","author":"Capla","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"R51-11-20211004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00223-002-2070-x","article-title":"Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women.","volume":"73","author":"Tanko","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"R52-11-20211004","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1359\/jbmr.1997.12.2.283","article-title":"Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures.","volume":"12","author":"Vogt","year":"1997","journal-title":"J Bone Miner Res"},{"key":"R53-11-20211004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1677\/joe.0.1590297","article-title":"Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.","volume":"159","author":"Jehle","year":"1998","journal-title":"J Endocrinol"},{"key":"R54-11-20211004","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/endo-122-1-254","article-title":"Insulin-like growth factor I has independent effects on bone matrix formation and cell replication.","volume":"122","author":"Hock","year":"1988","journal-title":"Endocrinology"},{"key":"R55-11-20211004","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00198-010-1310-6","article-title":"Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus.","volume":"22","author":"Kanazawa","year":"2011","journal-title":"Osteoporos Int"},{"key":"R56-11-20211004","first-page":"3276","article-title":"Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men.","volume":"85","author":"van den Beld","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R57-11-20211004","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2337\/dc06-1426","article-title":"Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.","volume":"30","author":"Kapoor","year":"2007","journal-title":"Diabetes Care"},{"key":"R58-11-20211004","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.2337\/dc07-0337","article-title":"The effects of hypogonadism on body composition and bone mineral density in type 2 diabetic patients.","volume":"30","author":"Dhindsa","year":"2007","journal-title":"Diabetes Care"},{"key":"R59-11-20211004","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2605.2010.01117.x","article-title":"Type 2 diabetes mellitus and testosterone: a meta-analysis study.","volume":"34","author":"Corona","year":"2010","journal-title":"Int J Androl"},{"key":"R60-11-20211004","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s001250050685","article-title":"Vitamin D, glucose tolerance and insulinaemia in elderly men.","volume":"40","author":"Baynes","year":"1997","journal-title":"Diabetologia"},{"key":"R61-11-20211004","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0026-0495(99)90201-9","article-title":"3rd, Horowitz M, Morley JE, et al. Longitudinal changes in serum 25-hydroxyvitamin D in older people.","volume":"48","author":"Perry","year":"1999","journal-title":"Metabolism"},{"key":"R62-11-20211004","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1210\/jc.2007-0298","article-title":"The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis.","volume":"92","author":"Pittas","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R63-11-20211004","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2337\/diacare.27.12.2813","article-title":"Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey.","volume":"27","author":"Scragg","year":"2004","journal-title":"Diabetes Care"},{"key":"R64-11-20211004","first-page":"1110","article-title":"To what extent is bone mass determined by fat-free or fat mass Am J Clin N","volume":"61","author":"Aloia","year":"1995","journal-title":"utr"},{"key":"R65-11-20211004","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1359\/jbmr.2001.16.11.2142","article-title":"Determinants of bone mineral density in older men and women: body composition as mediator.","volume":"16","author":"Pluijm","year":"2001","journal-title":"J Bone Miner Res"},{"key":"R66-11-20211004","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0969-8043(97)00101-2","article-title":"Muscle mass and fat mass in relation to bone mineral density in very old men and women: the Framingham Heart Study.","volume":"49","author":"Visser","year":"1998","journal-title":"Appl Radiat Isot"},{"key":"R67-11-20211004","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2796.2002.01050.x","article-title":"Fitness, fatness and activity as predictors of bone mineral density in older persons.","volume":"252","author":"Stewart","year":"2002","journal-title":"J Intern Med"},{"key":"R68-11-20211004","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2265.2010.03965.x","article-title":"Lean mass and fat mass predict bone mineral density in middle-aged individuals with noninsulin-requiring type 2 diabetes mellitus.","volume":"74","author":"Moseley","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R69-11-20211004","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jocd.2011.04.007","article-title":"Lean mass predicts hip geometry in men and women with noninsulin-requiring type 2 diabetes mellitus.","volume":"14","author":"Moseley","year":"2011","journal-title":"J Clin Densitom"},{"key":"R70-11-20211004","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2337\/dc09-2310","article-title":"Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS).","volume":"33","author":"Kim","year":"2010","journal-title":"Diabetes Care"},{"key":"R71-11-20211004","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1559-4564.2007.06673.x","article-title":"The cardiometabolic syndrome and sarcopenic obesity in older persons.","volume":"2","author":"Dominguez","year":"2007","journal-title":"J Cardiometab Syndr"},{"key":"R72-11-20211004","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/ajcn\/63.3.365","article-title":"Associations of fat and muscle masses with bone mineral in elderly men and women.","volume":"63","author":"Baumgartner","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"R73-11-20211004","first-page":"779","article-title":"Fat mass is an important determinant of whole body bone density in premenopausal women but not in men.","volume":"75","author":"Reid","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"R74-11-20211004","first-page":"45","article-title":"Determinants of total body and regional bone mineral density in normal postmenopausal women: a key role for fat mass.","volume":"75","author":"Reid","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"R75-11-20211004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1359\/jbmr.070813","article-title":"Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis.","volume":"23","author":"Zhao","year":"2008","journal-title":"J Bone Miner Res"},{"key":"R76-11-20211004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2009.04.004","article-title":"A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms.","volume":"310","author":"Confavreux","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"R77-11-20211004","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1359\/jbmr.2001.16.8.1426","article-title":"Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization.","volume":"16","author":"Reseland","year":"2001","journal-title":"J Bone Miner Res"},{"key":"R78-11-20211004","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1210\/endo.140.4.6637","article-title":"Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes.","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"R79-11-20211004","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00774-008-0861-5","article-title":"The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women.","volume":"26","author":"Jurimae","year":"2008","journal-title":"J Bone Miner Metab"},{"key":"R80-11-20211004","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/jn\/130.11.2813","article-title":"Leptin rapidly inhibits hypothalamic neuropeptide Y secretion and stimulates corticotropin-releasing hormone secretion in adrenalectomized mice.","volume":"130","author":"Jang","year":"2000","journal-title":"J Nutr"},{"key":"R81-11-20211004","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","article-title":"Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.","volume":"100","author":"Ducy","year":"2000","journal-title":"Cell"},{"key":"R82-11-20211004","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.metabol.2009.11.017","article-title":"Baseline serum total adiponectin level is positively associated with changes in bone mineral density after 1-year treatment of type 2 diabetes mellitus.","volume":"59","author":"Kanazawa","year":"2010","journal-title":"Metabolism"},{"key":"R83-11-20211004","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1359\/JBMR.040107","article-title":"Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women.","volume":"19","author":"Kontogianni","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R84-11-20211004","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-08-0642","article-title":"Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus.","volume":"160","author":"Kanazawa","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"R85-11-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(01)00697-4","article-title":"Age-related changes in the collagen network and toughness of bone.","volume":"31","author":"Wang","year":"2002","journal-title":"Bone"},{"key":"R86-11-20211004","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bone.2006.05.013","article-title":"Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae.","volume":"39","author":"Viguet-Carrin","year":"2006","journal-title":"Bone"},{"key":"R87-11-20211004","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00198-009-1066-z","article-title":"Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus.","volume":"21","author":"Saito","year":"2010","journal-title":"Osteoporos Int"},{"key":"R88-11-20211004","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1210\/jc.2008-2498","article-title":"Pentosidine and increased fracture risk in older adults with type 2 diabetes.","volume":"94","author":"Schwartz","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R89-11-20211004","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1210\/jc.2007-1270","article-title":"Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes.","volume":"93","author":"Yamamoto","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R90-11-20211004","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1474-9726.2008.00377.x","article-title":"Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts.","volume":"7","author":"Zhou","year":"2008","journal-title":"Aging Cell"},{"key":"R91-11-20211004","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.arr.2005.10.001","article-title":"Aging of mesenchymal stem cells.","volume":"5","author":"Sethe","year":"2006","journal-title":"Ageing Res Rev"},{"key":"R92-11-20211004","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nature03260","article-title":"Rejuvenation of aged progenitor cells by exposure to a young systemic environment.","volume":"433","author":"Conboy","year":"2005","journal-title":"Nature"},{"key":"R93-11-20211004","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00418-008-0391-1","article-title":"Exposure to pro-inflammatory cytokines upregulates MMP-9 synthesis by mesenchymal stem cells-derived osteoprogenitors.","volume":"129","author":"Ben David","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"R94-11-20211004","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.joca.2008.11.011","article-title":"Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation.","volume":"17","author":"Lacey","year":"2009","journal-title":"Osteoarthritis Cartilage"},{"key":"R95-11-20211004","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1089\/scd.2010.0009","article-title":"Persistent High Glucose Concentrations Alter the Regenerative Potential of Mesenchymal Stem Cells.","volume":"19","author":"Cramer","year":"2010","journal-title":"Stem Cells Dev"},{"key":"R96-11-20211004","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1359\/JBMR.050514","article-title":"Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone.","volume":"20","author":"Kume","year":"2005","journal-title":"J Bone Miner Res"},{"key":"R97-11-20211004","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1359\/jbmr.1997.12.3.439","article-title":"Advanced glycation endproducts stimulate interleukin-6 production by human bone-derived cells.","volume":"12","author":"Takagi","year":"1997","journal-title":"J Bone Miner Res"},{"key":"R98-11-20211004","first-page":"1","article-title":"Cellular and molecular effects of growth hormone and estrogen on human bone cells.","volume":"71","author":"Kassem","year":"1997","journal-title":"APMIS Suppl"},{"key":"R99-11-20211004","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/jama.2011.715","article-title":"Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes.","volume":"305","author":"Schwartz","year":"2011","journal-title":"JAMA"},{"key":"R100-11-20211004","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000223688","article-title":"Bone biopsy: indications and methods.","volume":"16","author":"Rauch","year":"2009","journal-title":"Endocr Dev"},{"issue":"Suppl 4","key":"R101-11-20211004","doi-asserted-by":"crossref","first-page":"iv3","DOI":"10.1093\/rheumatology\/kep273","article-title":"Microarchitecture, the key to bone quality.","volume":"48","author":"Brandi","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R102-11-20211004","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/jbmr.111","article-title":"Bone density, geometry, microstructure, and stiffness: Relationships between peripheral and central skeletal sites assessed by DXA, HR-pQCT, and cQCT in premenopausal women.","volume":"25","author":"Liu","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R103-11-20211004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00198-009-0945-7","article-title":"Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy.","volume":"21","author":"Cohen","year":"2010","journal-title":"Osteoporos Int"},{"key":"R104-11-20211004","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1210\/jc.2010-0226","article-title":"High-Resolution Peripheral Quantitative Computed Tomographic Imaging of Cortical and Trabecular Bone Microarchitecture in Patients with Type 2 Diabetes Mellitus.","volume":"95","author":"Burghardt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R105-11-20211004","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/jbmr.73","article-title":"Microindentation for in vivo measurement of bone tissue mechanical properties in humans.","volume":"25","author":"Diez-Perez","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R106-11-20211004","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00774-011-0265-9","article-title":"Quantitative ultrasound and vertebral fractures in patients with type 2 diabetes.","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Bone Miner Metab"},{"key":"R107-11-20211004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/gye.17.1.19.29","article-title":"Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements.","volume":"17","author":"Akin","year":"2003","journal-title":"Gynecol Endocrinol"},{"key":"R108-11-20211004","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s00198-005-1877-5","article-title":"Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus.","volume":"16","author":"Gerdhem","year":"2005","journal-title":"Osteoporos Int"},{"key":"R109-11-20211004","first-page":"2915","article-title":"Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover.","volume":"82","author":"Okazaki","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R110-11-20211004","first-page":"209","article-title":"Are antiresorptive drugs effective against fractures in patients with diabetes Calcif Tissue I","volume":"88","author":"Vestergaard","year":"2011","journal-title":"nt"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201204000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T01:47:22Z","timestamp":1633312042000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201204000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":110,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e328350a6e1","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}